Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

MYGN holding history

Myriad Genetics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MYGN overviewAll 13F holders of MYGNFull Q2 2026 holdings

Shares (Q2 2026)
4,582,083
Value
$26.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MYGN by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,582,083$26.2M<0.1%+82,359+1.8%AddedHolders
Q1 20264,499,724$20.2M<0.1%−5,469−0.1%ReducedHolders
Q4 20254,505,193$27.7M<0.1%−53,943−1.2%ReducedHolders
Q3 20254,559,136$33.0M<0.1%+47,639+1.1%AddedHolders
Q2 20254,511,497$24.0M<0.1%+1,988,879+78.8%AddedHolders
Q1 20252,522,618$22.4M<0.1%+702,804+38.6%AddedHolders
Q4 20241,819,814$24.9M<0.1%+668,429+58.1%AddedHolders
Q3 20241,151,385$31.5M<0.1%+24,638+2.2%AddedHolders
Q2 20241,126,747$27.6M<0.1%−139,366−11.0%ReducedHolders
Q1 20241,266,113$27.0M<0.1%−535,193−29.7%ReducedHolders
Q4 20231,801,306$34.5M<0.1%−376,619−17.3%ReducedHolders
Q3 20232,177,925$34.9M0.1%+150,903+7.4%AddedHolders
Q2 20232,027,022$47.0M0.1%+44,697+2.3%AddedHolders
Q1 20231,982,325$46.0M0.1%+125,025+6.7%AddedHolders
Q4 20221,857,300$26.9M<0.1%+100,834+5.7%AddedHolders
Q3 20221,756,466$33.5M0.1%−284,394−13.9%ReducedHolders
Q2 20222,040,860$37.1M0.1%+154,286+8.2%AddedHolders
Q1 20221,886,574$47.5M0.1%−21,030−1.1%ReducedHolders
Q4 20211,907,604$52.6M0.1%−101,258−5.0%ReducedHolders
Q3 20212,008,862$64.9M0.1%−233,807−10.4%ReducedHolders
Q2 20212,242,669$68.6M0.1%−417,038−15.7%ReducedHolders
Q1 20212,659,707$81.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.